BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 28426111)

  • 21. Review of the risks and benefits of yellow fever vaccination including some new analyses.
    Monath TP
    Expert Rev Vaccines; 2012 Apr; 11(4):427-48. PubMed ID: 22551029
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Yellow fever: an emerging threat for Kenya and other east African countries.
    Sanders EJ; Tukei PM
    East Afr Med J; 1996 Jan; 73(1):10-2. PubMed ID: 8625854
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of travel medicine practice by yellow fever vaccination centers in England, Wales, and Northern Ireland.
    Boddington NL; Simons H; Launders N; Gawthrop M; Stillwell A; Wong C; Mathewson J; Hill DR
    J Travel Med; 2012; 19(2):84-91. PubMed ID: 22414032
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevention of yellow fever in persons traveling to the tropics.
    Monath TP; Cetron MS
    Clin Infect Dis; 2002 May; 34(10):1369-78. PubMed ID: 11981733
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Yellow Fever in Angola and Beyond--The Problem of Vaccine Supply and Demand.
    Barrett AD
    N Engl J Med; 2016 Jul; 375(4):301-3. PubMed ID: 27276108
    [No Abstract]   [Full Text] [Related]  

  • 26. Notes from the Field: Knowledge, Attitudes, and Practices Regarding Yellow Fever Vaccination Among Men During an Outbreak - Luanda, Angola, 2016.
    Marlow MA; Pambasange MA; Francisco C; Receado OD; Soares MJ; Silva S; Navarro-Colorado C; Zielinski-Gutierrez E
    MMWR Morb Mortal Wkly Rep; 2017 Feb; 66(4):117-118. PubMed ID: 28151922
    [No Abstract]   [Full Text] [Related]  

  • 27. Global Risk and Elimination of Yellow Fever Epidemics.
    Ndeffo-Mbah ML; Pandey A
    J Infect Dis; 2020 Jun; 221(12):2026-2034. PubMed ID: 31545372
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is the absence or intermittent YF vaccination the major contributor to its persistent outbreaks in eastern Africa?
    Baba MM; Ikusemoran M
    Biochem Biophys Res Commun; 2017 Oct; 492(4):548-557. PubMed ID: 28109882
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative study of adverse events after yellow fever vaccination between elderly and non-elderly travellers: questionnaire survey in Japan over a 1-year period.
    Tanizaki R; Ujiie M; Hori N; Kanagawa S; Kutsuna S; Takeshita N; Hayakawa K; Kato Y; Ohmagari N
    J Travel Med; 2016 Mar; 23(3):. PubMed ID: 27021495
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recommendations for travellers during the yellow fever outbreaks in Brazil-2018.
    Fujita DM; da Silva Nali LH; Salvador FS; de Andrade Júnior HF
    J Travel Med; 2018 Jan; 25(1):. PubMed ID: 29635644
    [No Abstract]   [Full Text] [Related]  

  • 31. Yellow fever vaccines and international travelers.
    Barnett ED; Wilder-Smith A; Wilson ME
    Expert Rev Vaccines; 2008 Jul; 7(5):579-87. PubMed ID: 18564013
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Yellow fever urban outbreak in Angola and the risk of extension.
    Wkly Epidemiol Rec; 2016 Apr; 91(14):186-92. PubMed ID: 27066610
    [No Abstract]   [Full Text] [Related]  

  • 33. INFECTIOUS DISEASES. Yellow fever outbreak triggers vaccine alarm.
    Kupferschmidt K
    Science; 2016 Apr; 352(6282):128-9. PubMed ID: 27124428
    [No Abstract]   [Full Text] [Related]  

  • 34. Yellow fever vaccination coverage among children in Brazilian capitals.
    Veras MA; Flannery B; de Moraes JC; da Silva Teixeira AM; Luna EJ;
    Vaccine; 2010 Sep; 28(39):6478-82. PubMed ID: 20674878
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Yellow fever vaccination: is one dose always enough?
    Patel D; Simons H
    Travel Med Infect Dis; 2013; 11(5):266-73. PubMed ID: 24074827
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incidence, drivers and global health implications of the 2019/2020 yellow fever sporadic outbreaks in Sub-Saharan Africa.
    Uchenna Emeribe A; Nasir Abdullahi I; O R Ajagbe O; Egede Ugwu C; Oloche Onoja S; Dahiru Abubakar S; Modesta Umeozuru C; Sunday Animasaun O; Omoruyi Omosigho P; Mukhtar Danmusa U; Alhaji Baba Mallam M; Saidu Aminu M; Yahaya H; Oyewusi S
    Pathog Dis; 2021 Apr; 79(4):. PubMed ID: 33739369
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Yellow fever: the recurring plague.
    Tomori O
    Crit Rev Clin Lab Sci; 2004; 41(4):391-427. PubMed ID: 15487593
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Yellow fever – prevention in travellers.
    Arya SC
    Aust Fam Physician; 2010 Nov; 39(11):811. PubMed ID: 21387857
    [No Abstract]   [Full Text] [Related]  

  • 39. Eliminating yellow fever epidemics in Africa: Vaccine demand forecast and impact modelling.
    Jean K; Hamlet A; Benzler J; Cibrelus L; Gaythorpe KAM; Sall A; Ferguson NM; Garske T
    PLoS Negl Trop Dis; 2020 May; 14(5):e0008304. PubMed ID: 32379756
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Yellow fever cases in Asia: primed for an epidemic.
    Wasserman S; Tambyah PA; Lim PL
    Int J Infect Dis; 2016 Jul; 48():98-103. PubMed ID: 27156836
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.